Merit Medical Systems, Inc.
MMSIHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeMerit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United. At a $3.63B market cap, Merit Medical Systems, Inc. ranks as a mid-cap company within healthcare. It operates through two segments, Cardiovascular and Endoscopy.
Market Cap
$3.63B
Beta
0.57
P/E (TTM)
26.25
P/E (Fwd)
13.84
EPS (TTM)
$2.32
EPS (Fwd)
$4.40
ROE
9.1%
ROA
4.7%
Cash
$488.1M
Total Debt
$821.6M
Free CF
$178.2M
52W Change
-35.4%
Annual Financials
Cash vs Debt
Merit Medical Systems, Inc. carries $821.6M in total debt against $488.1M in cash reserves — debt is roughly 1.7x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $178.2M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 9.1% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.15B (2022) to $1.52B (2025), reflecting a 32% increase over the period.
With a beta below 0.7, Merit Medical Systems, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. No single metric tells the full story. Reviewing MMSI's risk profile alongside its fundamentals and technical indicators provides a more complete picture.